ORMP

Oramed Pharmaceuticals Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website oramed.com
Employees(FY) -
ISIN US68403P2039

Performance

-3.42%

-2.38%

-4.64%

-1.74%

-2.16%

YTD

+4.63%

Profile

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. The company's product portfolio includes ORMD-0801 Type 2, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes; ORMD-0801, Phase 2 oral insulin capsule for non-alcoholic steatohepatitis, a progressive liver diseases; and ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York.

Advanced Technical Analysis

Technical Analysis of ORMP 2024-11-20

The stock indicators reflect a bearish sentiment, with the Moving Average Score at 10, Oscillators Score at 36, and a Technical Score of 23, indicating overall weakness in price momentum and suggesting caution for potential investors. The low scores across all categories highlight a lack of bullish signals in the current market environment.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ORMP

Stock Rank

Recent News & Updates

2024-10-06 22:00
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt(Prnewswire)
2024-08-14 17:12
Oramed: Q2 Earnings Snapshot(Yahoo Finance)
2024-07-08 03:07
3 Micro-Cap Moonshots for Fearless Investors(Investorplace)
2024-06-25 21:05
Oramed Letter to Shareholders(Prnewswire)
2024-06-25 21:00
Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock(Prnewswire)
2024-05-09 11:53
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q1 2024(Investorplace)
2024-05-09 06:51
Oramed: Q1 Earnings Snapshot(Yahoo Finance)
2024-03-18 21:00
Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation(Globenewswire)
2024-03-06 21:53
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q4 2023(Investorplace)
2024-02-19 19:30
Oramed Letter to Shareholders(Prnewswire)
2023-11-09 16:03
Oramed: Q3 Earnings Snapshot(Yahoo Finance)
2023-10-23 20:30
PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization(Prnewswire)
2023-10-04 22:13
ORMP: Distribution Deals, JVs in Anticipation of Commercializing ORMD-0801(Yahoo Finance)
2023-09-21 23:38
Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company(Yahoo Finance)
2023-09-21 06:11
Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company(Yahoo Finance)
2023-09-21 04:05
Scilex Holding Company Announces the Consummation of the Previously Announced Purchase of all of the Scilex Common Shares, Preferred Shares and Warrants Owned by Sorrento Therapeutics, Inc.(Yahoo Finance)
2023-09-12 21:00
Scilex Holding Company Enters into Non-Binding Term Sheets for the Purchase of all of the Scilex Common Shares, Preferred Shares, and Warrants Currently Owned by Sorrento Therapeutics, Inc. and is Declared the New Successful Bidder(Yahoo Finance)
2023-08-01 19:45
Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally(Yahoo Finance)
2023-06-19 19:55
Oramed to Present at the 83rd American Diabetes Association Conference(Yahoo Finance)
2023-06-16 21:54
Oramed Pharmaceuticals (NASDAQ:ORMP) Is In A Good Position To Deliver On Growth Plans(Yahoo Finance)
2023-05-29 23:06
ORMP: Advancing Development Efforts in China(Yahoo Finance)
2023-05-17 19:55
Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit(Yahoo Finance)
2023-05-14 21:05
Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China(Yahoo Finance)
2023-05-12 01:03
Oramed: Q1 Earnings Snapshot(Yahoo Finance)
2023-05-01 22:51
Conservative Pundit Ben Shapiro Invests $4.7 Million in Israeli Drug Company(Yahoo Finance)
2023-05-01 04:45
Oramed Appoints Ben Shapiro to its Board of Directors(Yahoo Finance)
2023-03-26 18:57
The past year for Oramed Pharmaceuticals (NASDAQ:ORMP) investors has not been profitable(Yahoo Finance)
2023-02-08 18:55
Oramed Pharmaceuticals Issues Shareholder Update(Yahoo Finance)
2023-01-24 19:05
ORMP: ORA-D-013-1 Failed To Meet Endpoints; Ending T2D Oral Insulin Efforts(Yahoo Finance)
2023-01-11 23:30
Oramed Pharmaceuticals Stock Plummets After Insulin Test Results(Yahoo Finance)

Page 1 of 4

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.